Biotech AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis July 26, 2024
Biotech Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development July 26, 2024
Biotech IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication — Systemic Lupus Erythematosus (SLE) July 25, 2024
Biotech Merdury signs MOU with Health2Sync to conduct trial of Merdury’s StackDose technology intended for usage in GLP-1 (semaglutide) medication July 25, 2024
Biotech Ariceum Therapeutics Commences Phase 1 Clinical Trial in Patients with Recurrent Glioblastoma July 25, 2024
Biotech A Novel Way to Reduce Alzheimer’s Amyloid Plaque Burden, Phase 2 Clinical Trial Results of T3D-959 to be Presented by T3D Therapeutics at AAIC July 24, 2024
Biotech Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services July 24, 2024
Biotech Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class July 23, 2024
Biotech Nasal Polyposis Treatment Market to Reach US$ 6.8 Bn by 2034, Fueled by Rising Demand for Non-invasive Options: Transparency Market Research, Inc. July 23, 2024
Biotech Diamyd Medical receives positive feedback from FDA on potential Accelerated Approval for Diamyd® in Type 1 Diabetes July 23, 2024